My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 819

    1.

    The role of anti-malarial drugs in eliminating malaria.

    White NJ.

    Malar J. 2008 Dec 11;7 Suppl 1:S8. Review.PMID: 19091042 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations.

    Lawpoolsri S, Klein EY, Singhasivanon P, Yimsamran S, Thanyavanich N, Maneeboonyang W, Hungerford LL, Maguire JH, Smith DL.

    Malar J. 2009 Jul 15;8:159.PMID: 19604346 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.

    Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T.

    PLoS One. 2007 Oct 10;2(10):e1023.PMID: 17925871 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    UK malaria treatment guidelines.

    Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers.

    J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.PMID: 17215045 [PubMed - indexed for MEDLINE]Related articles

    5.

    Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.

    Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.

    Malar J. 2008 Nov 2;7:229.PMID: 18976503 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

    Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

    Malar J. 2009 Jan 5;8:2.PMID: 19123926 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Recent patent reviews on small molecule-based antimalarial drugs.

    Elsohly MA, Gul W.

    Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):222-32. Review.PMID: 18221180 [PubMed - indexed for MEDLINE]Related articles

    8.

    The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.

    Peters W, Stewart LB, Robinson BL.

    Ann Trop Med Parasitol. 2003 Apr;97(3):221-36.PMID: 12803854 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.

    White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP.

    Malar J. 2009 Nov 11;8:253.PMID: 19906307 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.

    Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC.

    PLoS Med. 2008 Nov 25;5(11):e226; discussion e226.PMID: 19067479 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Malaria: anti malarial resistance and policy ramifications and challenges.

    Kshirsagar NA.

    J Postgrad Med. 2006 Oct-Dec;52(4):291-3. Review.PMID: 17102549 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand.

    Ponsa N, Sattabongkot J, Kittayapong P, Eikarat N, Coleman RE.

    Am J Trop Med Hyg. 2003 Nov;69(5):542-7.PMID: 14695093 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Transmission-blocking activities of quinine, primaquine, and artesunate.

    Chotivanich K, Sattabongkot J, Udomsangpetch R, Looareesuwan S, Day NP, Coleman RE, White NJ.

    Antimicrob Agents Chemother. 2006 Jun;50(6):1927-30.PMID: 16723547 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.

    Vivas L, Rattray L, Stewart L, Bongard E, Robinson BL, Peters W, Croft SL.

    Acta Trop. 2008 Mar;105(3):222-8. Epub 2007 Dec 23.PMID: 18279817 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.

    Tangpukdee N, Krudsood S, Thanachartwet V, Pengruksa C, Phophak N, Kano S, Li G, Brittenham GM, Looareesuwan S, Wilairatana P.

    Southeast Asian J Trop Med Public Health. 2008 Jan;39(1):1-8.PMID: 18567436 [PubMed - indexed for MEDLINE]Related articles

    16.

    Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?

    Warhurst DC.

    Ann Trop Med Parasitol. 1984 Apr;78(2):165. No abstract available. PMID: 6378110 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials.

    Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ.

    Malar J. 2008 Jul 9;7:125.PMID: 18613962 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.

    Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ.

    Malar J. 2009 Feb 20;8:31.PMID: 19228438 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Artemisinin-based combination therapy for treating uncomplicated malaria.

    Sinclair D, Zani B, Donegan S, Olliaro P, Garner P.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. Review.PMID: 19588433 [PubMed - indexed for MEDLINE]Related articles

    20.

    Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.

    Shanks GD, Kain KC, Keystone JS.

    Clin Infect Dis. 2001 Aug 1;33(3):381-5. Epub 2001 Jul 5. Review.PMID: 11438908 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk